Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Inclusion Criteria: * Completed the short-term trial P05688, and judged by the investigator likely to benefit from continued treatment Exclusion Criteria: * Occurrence(s) of an adverse event or other clinically significant finding(s) in the short-term trial P05688 that would prohibit the participant's continuation into the long-term extension * Clinical Global Impression-Severity of Illness (CGI-S) score of ≥6 (severely psychotic) at Baseline * Newly diagnosed or discovered psychiatric condition that would have excluded the participant from participation in the short-term trial P05688